Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Fentanyl Increases Colorectal Carcinoma Cell Apoptosis by Inhibition of NF-κB in a Sirt1-dependent Manner

  • Zhang, Xiu-Lai (The Department of Anesthesiology and Surgery, International Healthcare Center, The Second Affiliated Hospital of Zhejiang University) ;
  • Chen, Min-Li (The Department of Anesthesiology and Surgery, International Healthcare Center, The Second Affiliated Hospital of Zhejiang University) ;
  • Zhou, Sheng-Li (The Department of Anesthesiology and Surgery, International Healthcare Center, The Second Affiliated Hospital of Zhejiang University)
  • Published : 2014.12.18
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Fentanyl is used as an analgesic to treat pain in a variety of patients with cancer and recently it has become considered to also act as an antitumor agent. The study present was designed to investigate the effects of fentanyl on colorectal cancer cell growth and plausible mechanisms. Materials and Methods: The human colorectal carcinoma cell line HCT116 was subcutaneously injected into nude mice. The viability of HCT116 was tested by MTT assay, and apoptosis by flow cytometry and caspase-3 activity. The expression of Sirt1 and NF-${\kappa}B$ were evaluated by Western blotting and the levels of Sirt1 and NF-${\kappa}B$ by fluorescence method. SiRNA was used to silence and Ad-Sirt1 to overexpress Sirt1. Results: Our data showed that fentanyl could inhibit tumor growth, with increased expression of Sirt1 and down-regulation of Ac-p65 in tumors. Compared with control cells without treatment, HCT116 cells that were incubated with fentanyl had a higher apoptotic rate. Moreover, fentanyl could increase expression and activity of Sirt1 and inhibitor expression and activity of NF-${\kappa}B$, which might be mechanisms of fentanyl action. Conclusions: Fentanyl increased colorectal carcinoma cell apoptosis by inhibition of NF-${\kappa}B$ activation in a Sirt1-dependent manner.

Keywords

References

  1. Aggarwal BB (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell, 6, 203-8. https://doi.org/10.1016/j.ccr.2004.09.003
  2. Bovill JG. (2010). Surgery for cancer: does anesthesia matter? Anesth Analg, 110, 1524-6. https://doi.org/10.1213/ANE.0b013e3181d8d183
  3. Chen LF, Greene WC (2004). Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol, 5, 392-401. https://doi.org/10.1038/nrm1368
  4. Domingo-Domenech J, Oliva C, Rovira A, et al (2006). Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. Clin Cancer Res, 12, 5578-86. https://doi.org/10.1158/1078-0432.CCR-05-2767
  5. Ford J, Jiang M, Milner J (2005). Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res, 65, 10457-63. https://doi.org/10.1158/0008-5472.CAN-05-1923
  6. Gang D, Hongwei H, Hedai L, et al (2013). The tumor suppressor protein menin inhibits NF-kappaB-mediated transactivation through recruitment of Sirt1 in hepatocellular carcinoma. Mol Biol Rep, 40, 2461-6. https://doi.org/10.1007/s11033-012-2326-0
  7. Ghosh S, May MJ, Kopp EB (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol, 16, 225-60. https://doi.org/10.1146/annurev.immunol.16.1.225
  8. Huffman DM, Grizzle WE, Bamman MM, et al (2007). SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res, 67, 6612-8. https://doi.org/10.1158/0008-5472.CAN-07-0085
  9. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  10. Jung W, Hong KD, Jung W Y, et al (2013). SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer. Korean J Pathol, 47, 332-9. https://doi.org/10.4132/KoreanJPathol.2013.47.4.332
  11. Kabra N, Li Z, Chen, L, et al (2009). SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem, 284, 18210-7. https://doi.org/10.1074/jbc.M109.000034
  12. Karin M, Yamamoto Y, Wang QM (2004). The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov, 3, 17-26. https://doi.org/10.1038/nrd1279
  13. Lee JH, Song MY, Song EK, et al (2009). Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes, 58, 344-51. https://doi.org/10.2337/db07-1795
  14. Lennon FE, Mirzapoiazova T, Mambetsariev B, et al (2014). The Mu opioid receptor promotes opioid and growth factorinduced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PloS one, 9, 91577. https://doi.org/10.1371/journal.pone.0091577
  15. Lennon FE, Moss J, Singleton PA (2012). The mu-opioid receptor in cancer progression: is there a direct effect? Anesthesiology, 116, 940-5. https://doi.org/10.1097/ALN.0b013e31824b9512
  16. Lv L, Shen Z, Zhang J, et al (2014). Clinicopathological significance of SIRT1 expression in colorectal adenocarcinoma. Med Oncol, 31, 965. https://doi.org/10.1007/s12032-014-0965-9
  17. Nuckols TK, Anderson L, Popescu I, et al (2014). Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med, 160, 38-47.
  18. Qin Y, Li L, Chen J, et al (2012). Fentanyl inhibits progression of human gastric cancer MGC-803 cells by NF-kappaB downregulation and PTEN upregulation in vitro. Oncol Res, 20, 61-9. https://doi.org/10.3727/096504012X13473664562501
  19. Xu TP, Shen H, Liu LX, Shu YQ (2013). Plumbagin from Plumbago Zeylanica L induces apoptosis in human nonsmall cell lung cancer cell lines through NF- ${\kappa}B$ inactivation. Asian Pac J Cancer Prev, 14, 2325-31 https://doi.org/10.7314/APJCP.2013.14.4.2325
  20. Yeung F, Hoberg JE, Ramsey CS, et al (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J, 23, 2369-80. https://doi.org/10.1038/sj.emboj.7600244
  21. Yi J, Luo J (2010). SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta, 1804, 1684-9. https://doi.org/10.1016/j.bbapap.2010.05.002

Cited by

  1. miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3645
  2. Salidroside suppresses inflammation in a D-galactose-induced rat model of Alzheimer’s disease via SIRT1/NF-κB pathway vol.31, pp.4, 2016, https://doi.org/10.1007/s11011-016-9813-2
  3. Fentanyl induces autophagy via activation of the ROS/MAPK pathway and reduces the sensitivity of cisplatin in lung cancer cells vol.36, pp.6, 2016, https://doi.org/10.3892/or.2016.5183
  4. Fentanyl inhibits the progression of human gastric carcinoma MGC-803 cells by modulating NF-κB-dependent gene expression in vivo vol.12, pp.1, 2016, https://doi.org/10.3892/ol.2016.4619